Covid-19 vaccines: Which country will get them when in Southeast Asia

With countries in Southeast Asia struggling with new waves of Covid-19 infections, many are wondering when vaccinations are going to start in the 650-million people region and what sort of vaccine each country will use.

Bloomberg News, among others, has compiled the latest information on the issue for the major economies in Southeast Asia in the race to immunise people against the coronavirus.

Singapore has become the first to start an official Covid-19 vaccination program on December 30, beginning to inoculate healthcare workers in the national infectious diseases center.

Indonesia, which was the first in the region to receive a vaccine shipment, needs to wait for more data before approving China’s Sinovac vaccine.

Overall, Indonesia seeks to vaccinate up to 182 million people, prioritising those aged 18 to 59 years old. The country is banking on both Western and Chinese vaccines, ordering 125.5 million doses from Sinovac, 50 million from AstraZeneca and another 50 million from Novavax, while developing 57.6 million of its own vaccine Merah Putih.

The government in Jakarta is also seeking to secure another 54 million from the global GAVI vaccine facility while talks are also on with Pfizer/BioNTech for 50 million doses and loaned cold storage facilities for the vaccine.

The country plans to vaccinate 16 million people a month for free.

The Philippines wants to have at least 50 million vaccine shots to inoculate about a fourth of the population, the bulk of which will likely arrive by the end of 2021 or early 2022. Priority for vaccinations will be given to medical front liners and workers in industries deemed critical, including low-income groups and those identified as at risk.

The nation expects to sign a deal for the Pfizer/BioNTech vaccine by January and is also working on a pact with Moderna for an initial 20 million doses. It is aiming to secure at least 80 million vaccines from pharmaceuticals companies including AstraZeneca, Novavax and Johnson & Johnson.

The government is also asking Russia’s Gamaleya National Center of Epidemiology and Microbiology, which is offering another 25 million doses, to submit the results of its third clinical trial, while discussions with Sinovac are ongoing.

Malaysia is spending $504 million to buy enough shots to cover 26.5 million people, or about 80 per cent of its population.

The country is set to secure 12.8 million doses of the AstraZeneca vaccine, enough to inoculate 20 per cent of the country’s population. The first batch is expected in the second quarter of 2021.

The government is also in final negotiations with China’s Sinovac for 14 million doses, with CanSino Biologics for 3.5 million doses and for 6.4 million shots of Russia’s Sputnik V vaccine.

Singapore has laid out a strategy by setting aside roughly $754 million for vaccines, tapping the likes of Arcturus Therapeutics, Moderna, Pfizer/BioNTech and Sinovac for supplies. It estimates it should have enough for the 5.5-million population by the third quarter of 2021. Front liners, the elderly and vulnerable will be prioritised in the nation’s vaccination program, and vaccines will be free for all Singaporeans and long-term residents.

Thailand wants to inoculate about 50 per cent of its population by next year. The country plans to get 26 million doses from the World Health Organization-backed Covax program, 26 million from AstraZeneca, and 13 million more from other sources, providing immunity to more than 30 million people. Not wanting to rely solely on inoculations from abroad, Thailand is also developing its own anti-coronavirus jab.

The domestic vaccine research project is set to start the first phase of clinical trials in April, and the second phase in June. The vaccines may be available by end-2021 after receiving emergency-use authorisation.

Vietnam is working on developing vaccines and will approach suppliers when vaccines are available, according to a spokeswoman at the foreign affairs ministry. The country is in talks with Pfizer/BioNTech and other medicine manufacturers in the US, UK, China and Russia on acquiring coronavirus shots.

In mid-December, Vietnam also started first-phase clinical trials of its domestic coronavirus vaccine Nanocovax, developed by Vietnam’s Nonogen Pharmaceutical Biotechnology, with production expected to start in 2022 if tests are successful. Two other Vietnamese vaccine manufacturers will start human trials for their coronavirus shots in February and March

As for the other countries in the region, Laos has said it expects to receive and distribute a Covid-19 vaccine at some point in 2021, which will most likely come from the UK. In Cambodia, the government aims to vaccinate up to ten million of its citizens as a preventive measure against the pandemic, but has said it will not rely on Chinese vaccines.

In Myanmar, vaccinations are expected to start in April for to about 20 per cent of the country’s 54-million population under the global Covax affordable medicines program, while in Brunei, the government aims to commence vaccinations in the first quarter, initially also under the Covax programme.



Support ASEAN news

Investvine has been a consistent voice in ASEAN news for more than a decade. From breaking news to exclusive interviews with key ASEAN leaders, we have brought you factual and engaging reports – the stories that matter, free of charge.

Like many news organisations, we are striving to survive in an age of reduced advertising and biased journalism. Our mission is to rise above today’s challenges and chart tomorrow’s world with clear, dependable reporting.

Support us now with a donation of your choosing. Your contribution will help us shine a light on important ASEAN stories, reach more people and lift the manifold voices of this dynamic, influential region.

$
Personal Info

Donation Total: $10.00

 

 

With countries in Southeast Asia struggling with new waves of Covid-19 infections, many are wondering when vaccinations are going to start in the 650-million people region and what sort of vaccine each country will use. Bloomberg News, among others, has compiled the latest information on the issue for the major economies in Southeast Asia in the race to immunise people against the coronavirus. Singapore has become the first to start an official Covid-19 vaccination program on December 30, beginning to inoculate healthcare workers in the national infectious diseases center. Indonesia, which was the first in the region to receive a...

With countries in Southeast Asia struggling with new waves of Covid-19 infections, many are wondering when vaccinations are going to start in the 650-million people region and what sort of vaccine each country will use.

Bloomberg News, among others, has compiled the latest information on the issue for the major economies in Southeast Asia in the race to immunise people against the coronavirus.

Singapore has become the first to start an official Covid-19 vaccination program on December 30, beginning to inoculate healthcare workers in the national infectious diseases center.

Indonesia, which was the first in the region to receive a vaccine shipment, needs to wait for more data before approving China’s Sinovac vaccine.

Overall, Indonesia seeks to vaccinate up to 182 million people, prioritising those aged 18 to 59 years old. The country is banking on both Western and Chinese vaccines, ordering 125.5 million doses from Sinovac, 50 million from AstraZeneca and another 50 million from Novavax, while developing 57.6 million of its own vaccine Merah Putih.

The government in Jakarta is also seeking to secure another 54 million from the global GAVI vaccine facility while talks are also on with Pfizer/BioNTech for 50 million doses and loaned cold storage facilities for the vaccine.

The country plans to vaccinate 16 million people a month for free.

The Philippines wants to have at least 50 million vaccine shots to inoculate about a fourth of the population, the bulk of which will likely arrive by the end of 2021 or early 2022. Priority for vaccinations will be given to medical front liners and workers in industries deemed critical, including low-income groups and those identified as at risk.

The nation expects to sign a deal for the Pfizer/BioNTech vaccine by January and is also working on a pact with Moderna for an initial 20 million doses. It is aiming to secure at least 80 million vaccines from pharmaceuticals companies including AstraZeneca, Novavax and Johnson & Johnson.

The government is also asking Russia’s Gamaleya National Center of Epidemiology and Microbiology, which is offering another 25 million doses, to submit the results of its third clinical trial, while discussions with Sinovac are ongoing.

Malaysia is spending $504 million to buy enough shots to cover 26.5 million people, or about 80 per cent of its population.

The country is set to secure 12.8 million doses of the AstraZeneca vaccine, enough to inoculate 20 per cent of the country’s population. The first batch is expected in the second quarter of 2021.

The government is also in final negotiations with China’s Sinovac for 14 million doses, with CanSino Biologics for 3.5 million doses and for 6.4 million shots of Russia’s Sputnik V vaccine.

Singapore has laid out a strategy by setting aside roughly $754 million for vaccines, tapping the likes of Arcturus Therapeutics, Moderna, Pfizer/BioNTech and Sinovac for supplies. It estimates it should have enough for the 5.5-million population by the third quarter of 2021. Front liners, the elderly and vulnerable will be prioritised in the nation’s vaccination program, and vaccines will be free for all Singaporeans and long-term residents.

Thailand wants to inoculate about 50 per cent of its population by next year. The country plans to get 26 million doses from the World Health Organization-backed Covax program, 26 million from AstraZeneca, and 13 million more from other sources, providing immunity to more than 30 million people. Not wanting to rely solely on inoculations from abroad, Thailand is also developing its own anti-coronavirus jab.

The domestic vaccine research project is set to start the first phase of clinical trials in April, and the second phase in June. The vaccines may be available by end-2021 after receiving emergency-use authorisation.

Vietnam is working on developing vaccines and will approach suppliers when vaccines are available, according to a spokeswoman at the foreign affairs ministry. The country is in talks with Pfizer/BioNTech and other medicine manufacturers in the US, UK, China and Russia on acquiring coronavirus shots.

In mid-December, Vietnam also started first-phase clinical trials of its domestic coronavirus vaccine Nanocovax, developed by Vietnam’s Nonogen Pharmaceutical Biotechnology, with production expected to start in 2022 if tests are successful. Two other Vietnamese vaccine manufacturers will start human trials for their coronavirus shots in February and March

As for the other countries in the region, Laos has said it expects to receive and distribute a Covid-19 vaccine at some point in 2021, which will most likely come from the UK. In Cambodia, the government aims to vaccinate up to ten million of its citizens as a preventive measure against the pandemic, but has said it will not rely on Chinese vaccines.

In Myanmar, vaccinations are expected to start in April for to about 20 per cent of the country’s 54-million population under the global Covax affordable medicines program, while in Brunei, the government aims to commence vaccinations in the first quarter, initially also under the Covax programme.



Support ASEAN news

Investvine has been a consistent voice in ASEAN news for more than a decade. From breaking news to exclusive interviews with key ASEAN leaders, we have brought you factual and engaging reports – the stories that matter, free of charge.

Like many news organisations, we are striving to survive in an age of reduced advertising and biased journalism. Our mission is to rise above today’s challenges and chart tomorrow’s world with clear, dependable reporting.

Support us now with a donation of your choosing. Your contribution will help us shine a light on important ASEAN stories, reach more people and lift the manifold voices of this dynamic, influential region.

$
Personal Info

Donation Total: $10.00

 

 

NO COMMENTS

Leave a Reply